Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pelvic and Aortic-cava Lymphadenectomy Randomized Phase III for Advanced Ovarian Cancer

NCT01218490 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.

NCT NCT01218490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pelvic and Aortic-cava Lymphadenectomy Randomized Phase III for Advanced Ovarian Cancer
Lead sponsor
Institut Cancerologie de l'Ouest
Phase
Phase 3
Overall status
Suspended
Start date
December 9, 2008
Completion date
May 31, 2026
Enrollment
450 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer